News and Press

A recent study has demonstrated that machine learning methods can sort out which laboratory tests used in hospitals may have greater patient-care value, and which ones don’t. Laboratory testing firm Quest Diagnostics and healthcare solutions company hc1 announced a partnership…

The strategic collaboration aims to improve patient care and reduce costs across thousands of health systems nationwide by delivering insights that empower optimal lab testing.

Quest Diagnostics and bioinformatics company hc1 have announced the debut of Quest Lab Stewardship, a machine learning-powered program for tracking and monitoring the appropriateness of lab testing across health systems.

Quest Diagnostics and hc1 team up in order to launch service for optimizing lab test utilization. Quest uses hc1’s machine learning technology to collect and analyze lab data, allowing systems to identify areas where usage is inappropriate or inefficient.

Lab testing giant Quest Diagnostics has teamed up with healthcare data analysis company hc1 to try to prevent health systems from ordering too many or too few tests.

The Tech Tribune staff has compiled the very best tech startups in Indianapolis, Indiana. In doing our research, we considered several factors including but not limited to: Revenue potential Leadership team Brand/product traction Competitive landscape Additionally, all companies must be independent…

The Regenstrief Institute is joining with hc1.com, a cloud-based precision health vendor, to analyze data to uncover the factors that lead to substance use disorder, overdoses and drug-related deaths.

hc1.com®, the leader in precision health that ensures the right person gets the right test and the right prescription, announced its new hc1 Rx Optimization™ product offering that helps physicians and pharmacists tailor prescriptions for each individual patient with on…

An Indianapolis medical-software firm is expanding its reach into the fast-growing areas of opioid prescription management and precision medicine, in which treatment is determined in part by genetic testing. bostic-brad-mug-tech-executive.jpg Bostic Hc1.com recently raised $10 million in venture funding…

hc1.com® announced today that existing investor Health Cloud Capital has exercised its option to provide additional growth funding, bringing the company’s total Series B capital raise to $10 million. Elevate Ventures also participated in the round. The additional capital will…

The head of business development at a leading toxicology lab had an “ah-ha” moment when he compared two of the lab’s accounts. He was surprised to discover that the account with 50 percent fewer test orders was highly profitable, while…

Long-term and post-acute care (LT/PAC) has been behind the curve when it comes to employing metrics. But with the skilled nursing profession becoming more competitive, and with reimbursement rates being squeezed by new regulations and value-based care initiatives, making important…